Chinese Markets for Alzheimer Disease Drugs

Table of Contents

I.INTRODUCTION

• Report Scope and Methodology
• Executive Summary

II.BUSINESS ENVIRONMENT

• Economic Outlook
• Key Economic Indicators
• Industrial Output
• Population and Labor
• Foreign Investment
• Foreign Trade
• Financial and Tax Regulations
• Banking System and Regulations
• Foreign Exchange
• Taxes, Tariff and Custom Duties

III.ALZHEIMER' S DISEASE DRUGS INDUSTRY ASSESSMENTS

• Alzheimer' s Disease Drugs Industry Structure
• Market Size
• Market Growth Drivers
• Alzheimer' s Disease Drugs Sales Volume
• Major Producer Facility Locations and Sales Volume
• Market Share of Key Producers
• Labor Cost
• Potential Entrants
• Major Distributors
• Major Foreign Investments
• Technology Development

IV. ALZHEIMER' S DISEASE DRUGS PRODUCTION AND DEMAND

• Overview
• Demand of Alzheimer' s Disease Drugs by Region
• Alzheimer' s Disease Drugs Sales Volume
• Ginkgo Bilota Extract
• Breviscapine
• Ganglioside
• Donepezil
• Galanthamine
• Nicergoline
• Rivastigmine
• Memantine
• Huperzine A
• Oxiracetam
• Flunarizine
• Piracetam
• Other Alzheimer' s Disease Drugs
• Alzheimer' s Disease Drugs Imports
• Ginkgo Bilota Extract Imports
• Breviscapine Imports
• Ganglioside Imports
• Donepezil Imports
• Galanthamine Imports
• Nicergoline Imports
• Rivastigmine Imports
• Memantine Imports
• Huperzine A Imports
• Oxiracetam Imports
• Flunarizine Imports
• Piracetam Imports
• Other Alzheimer' s Disease Drugs Imports
• Pricing Trend

V. ALZHEIMER' S DISEASE DRUGS MARKET OUTLOOK

• Alzheimer' s Disease Drugs Markets Outlook Overview
• Government Regulations
• Health Care Insurance Industry Overview
• Consumer Spending Trends
• Demographic Trends
• Health Care Industry Trends
• Hospitals and Hospital Beds
• Physicians and Physician Visits

VI. MARKETING STRATEGIES

• China Market Entry Overview
• China' s Distribution System
• Alzheimer' s Disease Drugs Distribution Channels
• Transportation and Freight Infrastructure
• Communications
• China' s Market Entry
• Export to China
• Indirect export
• Direct Export
• License and Contract Manufacture
• Assembling in China
• Contract Manufacturing
• Trade Permit
• Investment
• Equity Joint Venture
• Contractual Joint Venture
• Wholly Foreign-Owned Enterprise

VII. ALZHEIMER' S DISEASE DRUGS PRODUCER DIRECTORY

• Major Alzheimer' s Disease Drugs Producer Profiles
• Distributors and Trading Companies
• Associations and Research Institutes
• Major End-Users

LIST OF TABLES

I. INTRODUCTION

• Economic Outlook Summary

II. BUSINESS ENVIRONMENT

• Key Economic Indicators
• Industrial Output
• Population and Labor Force Trends
• Foreign Investment and Loans
• Foreign Trade

III. ALZHEIMER' S DISEASE DRUGS INDUSTRY ASSESSMENTS

• Alzheimer' s Disease Drugs Sales Volume
• Major Producer Facility Locations
• Major Alzheimer' s Disease Drugs Producer Sales Volume
• Market Share of Key Producers
• Major Foreign Investments

IV. ALZHEIMER' S DISEASE DRUGS PRODUCTION AND DEMAND

• Total Alzheimer' s Disease Drugs Sales Volume
• Alzheimer' s Disease Drugs Major Producer and Their Market Share
• Ginkgo Bilota Extract Major Producer and Their Market Share
• Breviscapine Major Producer and Their Market Share
• Ganglioside Major Producer and Their Market Share
• Donepezil Major Producer and Their Market Share
• Galanthamine Major Producer and Their Market Share
• Dihydroergotamine Major Producer and Their Market Share
• Rivastigmine Major Producer and Their Market Share
• Memantine Major Producer and Their Market Share
• Huperzine A Major Producer and Their Market Share
• Oxiracetam Major Producer and Their Market Share
• Flunarizine Major Producer and Their Market Share
• Piracetam Major Producer and Their Market Share
• Alzheimer' s Disease Drugs Import

V. ALZHEIMER' S DISEASE DRUGS MARKET OUTLOOK

• Consumer Spending Trend
• Demographic Trends
• Health Care Industry Trends
• Hospitals and Hospital Beds
• Physicians and Physician Visits

LIST OF CHARTS

I. NTRODUCTION

• Alzheimer' s Disease Drugs Sales Volume

II. BUSINESS ENVIRONMENT

• China' s GDP and Industrial Output
• Industrial Output by Ownership
• China' s Imports and Exports

III. ALZHEIMER' S DISEASE DRUGS INDUSTRY ASSESSMENTS

• Alzheimer' s Disease Drugs Sales Volume

IV. ALZHEIMER' S DISEASE DRUGS PRODUCTION AND DEMAND

• Alzheimer' s Disease Drugs Sales Volume
• Worldwide Alzheimer' s Disease Drugs Demand by Region
• Ginkgo Bilota Extract Sales Volume and Market Share
• Breviscapine Sales Volume and Market Share
• Ganglioside Sales Volume and Market Share
• Donepezil Sales Volume and Market Share
• Galanthamine Sales Volume and Market Share
• Dihydroergotamine Sales Volume and Market Share
• Rivastigmine Sales Volume and Market Share
• Memantine Sales Volume and Market Share
• Huperzine A Sales Volume and Market Share
• Oxiracetam Sales Volume and Market Share
• Flunarizine Sales Volume and Market Share
• Piracetam Sales Volume and Market Share
• Other Alzheimer' s Disease Drugs Sales volume and market share
• Alzheimer' s Disease Drugs Import Volume
• Ginkgo Bilota Extract Import Volume and Market Share
• Breviscapine Import Volume and Market Share
• Ganglioside Import Volume and Market Share
• Donepezil Import Volume and Market Share
• Galanthamine Import Volume and Market Share
• Dihydroergotamine Import Volume and Market Share
• Rivastigmine Import Volume and Market Share
• Memantine Import Volume and Market Share
• Huperzine A Import Volume and Market Share
• Oxiracetam Import Volume and Market Share
• Flunarizine Import Volume and Market Share
• Piracetam Import Volume and Market Share
• Other Alzheimer' s Disease Drugs Import Volume and Market Share

VI. MARKETING STRATEGIES

• China' s Distribution Channel